Percutaneous Coronary Intervention of Unprotected Left Main Coronary Artery in Cardiac Allograft Vasculopathy: A Case Series of Pediatric Patients

Authors

  • Hambik H. Tankazyan Loma Linda University Medical Center
  • Liset N. Stoletniy
  • Antoine Sakr
  • Kenneth R. Jutzy
  • Anthony A. Hilliard

DOI:

https://doi.org/10.17987/icfj.v4i0.139

Abstract

Cardiac allograft vasculopathy is a major cause of morbidity and mortality in orthotopic heart transplantation. The optimal management remains uncertain, especially in left main coronary artery lesions. With the limited data available in the literature, we present a review of three pediatric cases of cardiac allograft vasculopathy, involving the left main coronary artery, treated with percutaneous coronary intervention.

Author Biography

Hambik H. Tankazyan, Loma Linda University Medical Center

Department of Internal Medicine, Division of Cardiology at Loma Linda University Medical Center

Primary author is a Fellow of Cardiovascular Disease

References

Lund LH, Edwards LB, Kucheryavaya AY, et al; International Society for Heart and Lung Transplantation. The registry of the international society for heart and lung transplantation: thirtieth official adult heart transplant report-2013; focus theme: age. J Heart Lung Transplant. 2013;32(10):951-964.

Tadwalkar, RV, Lee MS; Unprotected Left Main Coronary Artery Percutaneous Coronary Intervention in a Pediatric Patient With Cardiac Allograft Vasculopathy. J Invasive Cardiol. 2014;26(11):E156-E160

Simpson L, Lee EK, Hott BJ, Vega DJ, Book WM. Long-term results of angioplasty vs stenting in cardiac transplant recipients with allograft vasculopathy. J Heart Lung Transplant. 2005;24(9):1211-1217.

Lee MS, Yang T, et al; Long-term outcomes after percutaneous coronary intervention of left main coronary artery for treatment of cardiac allograft vasculopathy after orthotopic heart transplantation. Am J Cardiol, 2010 Oct 15;106(8):1086-9

Tankazyan, H, Stoletniy, L, Jutzy, K, Hilliard, A; Impella® Assisted Percutaneous Coronary Intervention of Unprotected Left Main Coronary Artery Stenosis in Cardiac Allograft Vasculopathy – A Case Report

Shewan LG, Coats AJS, Henein M. Requirements for ethical publishing in biomedical journals. International Cardiovascular Forum Journal 2015;2:2 DOI: 10.17987/icfj.v2i1.4

Downloads

Published

2015-12-04

Issue

Vol. 4 (2015)

Section

Letters to the Editor

License

Authors who publish with this journal agree to the following terms:


a. The authors will retain copyright under a Creative Commons Attribution License (CC-BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).